A 72-year-old woman with a 15-year history of multiple myeloma (IgG lambda) is found to have progressive dyspnea and orthopnea. Echocardiography shows restrictive physiology with preserved ejection fraction. Serum free light chain ratio is markedly elevated (lambda 850 mg/L, kappa 15 mg/L). Which investigation is most specific for confirming cardiac amyloidosis?

Explanation

## Diagnosis of Cardiac Amyloidosis **Key Point:** Endomyocardial biopsy with Congo red staining (for amyloid confirmation) and mass spectrometry (for amyloid typing) is the most specific investigation for cardiac amyloidosis. It provides definitive tissue diagnosis and allows identification of the amyloid type (AL vs. ATTR). ### Why Endomyocardial Biopsy Is Superior 1. **Direct tissue diagnosis**: Confirms amyloid deposition in the myocardium 2. **Congo red positivity**: Apple-green birefringence under polarized light is pathognomonic 3. **Amyloid typing**: Mass spectrometry or immunohistochemistry identifies the amyloid protein (AL light chain vs. ATTR) 4. **Highest specificity**: >99% specificity; no false positives 5. **Prognostic value**: Allows risk stratification and guides therapy (e.g., chemotherapy for AL vs. supportive care for ATTR) ### Imaging vs. Tissue Diagnosis in Cardiac Amyloidosis | Investigation | Sensitivity | Specificity | Diagnostic | Clinical Use | |---|---|---|---|---| | **Endomyocardial biopsy + Congo red** | 85–95% | **>99%** | **YES (gold standard)** | Definitive diagnosis + typing | | Cardiac MRI (LGE) | 80–90% | 85–90% | Suggestive, not diagnostic | Phenotyping, staging | | Echo strain imaging | 70–80% | 60–70% | Suggestive, not diagnostic | Screening, prognostic | | Tc-99m pyrophosphate | 60–80% | 70–80% | Suggestive (ATTR-specific) | ATTR screening | | Serum biomarkers (troponin, BNP) | Variable | Low | Non-specific | Risk stratification | **High-Yield:** In this case, the patient has **AL amyloidosis** (IgG lambda myeloma with elevated lambda free light chains). Endomyocardial biopsy is essential to: - Confirm amyloid in the heart - Distinguish AL from ATTR (which would have normal free light chains) - Guide aggressive chemotherapy vs. conservative management ### Clinical Pearl Cardiac MRI with late gadolinium enhancement (LGE) shows a characteristic **diffuse subendocardial or transmural pattern**, but this is suggestive, not diagnostic. Many other conditions (e.g., hypertrophic cardiomyopathy, sarcoidosis) can mimic this pattern. **Only tissue biopsy confirms amyloidosis.** ### Mnemonic: BIOPSY WINS - **B**iopsy confirms amyloid (Congo red) - **I**dentifies amyloid type (mass spectrometry) - **O**rgan-specific (myocardium) - **P**rognostic information (risk stratification) - **S**pecificity >99% - **Y**ields definitive diagnosis - **W**hile imaging is suggestive only - **I**maging cannot type amyloid - **N**eeds tissue for certainty - **S**upports treatment decisions **Warning:** Do not rely on imaging alone (MRI, echo, scintigraphy) for diagnosis. These are screening and staging tools. Tissue biopsy is mandatory for definitive diagnosis and amyloid typing in cardiac amyloidosis.